Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Net Current Assets

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Current Assets (Including Current Investments) ₹1,322 Cr₹4,446 Cr₹2,461 Cr₹1,780 Cr₹2,526 Cr

What is the latest Net Current Assets ratio of MANKIND PHARMA ?

The latest Net Current Assets ratio of MANKIND PHARMA is ₹1,322 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹1,322 Cr
Mar2024₹4,446 Cr
Mar2023₹2,461 Cr
Mar2022₹1,780 Cr
Mar2021₹2,526 Cr

How is Net Current Assets of MANKIND PHARMA Trending?

Years Net Current Assets % Change
Mar2025 ₹1,322 Cr
-70.26
Mar2024 ₹4,446 Cr
80.62
Mar2023 ₹2,461 Cr
38.25
Mar2022 ₹1,780 Cr
-29.52
Mar2021 ₹2,526 Cr -

Compare Net Current Assets of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹101,633.1 Cr 1.8% 1.8% 6.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,792.0 Cr 1.4% 1.2% 13.8% Stock Analytics
DIVIS LABORATORIES ₹178,152.0 Cr -0.5% -0.6% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,915.0 Cr 2.1% 1.5% 42.2% Stock Analytics
CIPLA ₹116,354.0 Cr 6.4% 1.6% -3.1% Stock Analytics
DR REDDYS LABORATORIES ₹112,681.0 Cr 6.2% 1.6% 0.2% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.8%

1.8%

6.6%

SENSEX

-0.4%

0.8%

-5.3%


You may also like the below Video Courses